Document Details
Form
Filing Date
Nov 28, 2023
Document Date
Nov 24, 2023
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
SAB Biotherapeutics
Issuer
SAB BIOTHERAPEUTICS, INC.
Filer
Sessa Capital (Master), L.P.